RecruitingNCT06779058

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

Retrospective and Prospective Multi-center Clinical Study of Magnetic Resonance Elastography in Evaluating Hepatic Fibrosis in Chronic Viral Hepatitis B


Sponsor

Shengjing Hospital

Enrollment

600 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

How to construct a non-invasive, accurate, and convenient method to evaluate the severity of liver fibrosis (LF) is an important general problem in the management of patients with chronic hepatitis B (CHB). We plan to investigate the ability of magnetic resonance elastography (MRE) to grade fibrosis in chronic hepatitis B and apply to clinical longitudinal follow-up.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Liver biopsy and a medical device called MRE for people with chronic hepatitis b and liver fibrosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRE

All imaging studies were performed by using a 1.5T/3.0-T MRI system

DEVICELiver biopsy

Liver biopsy are performed by well-trained pathologists in accordance with standard operating procedures.


Locations(1)

Shengjing Hospital

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06779058


Related Trials